Genvor, Inc. Presenting at NIBA’s 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 | National

CEO Chad Pawlak to deliver corporate update on AI-accelerated peptide platform and strategic growth initiatives

WOODLAND, CA / ACCESS Newswire / March 5, 2026 / Genvor, Inc. (OTCQB:GNVR) (“Genvor” or the “Company”) is pleased to announce that Chief Executive Officer Chad Pawlak will be presenting at the National Investment Banking Association’s (NIBA) 152nd Investment Conference in Fort Lauderdale, Florida on March 12, 2026.

The presentation will include a corporate update highlighting the Company’s recent milestones, technology platform advancements and upcoming growth initiatives. Attendees and investors are encouraged to schedule one-on-one meetings with management during the conference.

Genvor, Inc. (OTCQB:GNVR) is a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health. Genvor’s proprietary BioCypher platform designs peptides that enhance crop performance, reduce chemical inputs, and support human recovery and wellness. Through strategic partnerships and a dual-market commercialization model, Genvor is advancing peptide science from field to finish line. For more information, visit www.genvor.com.

About National Investment Banking Association

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied. Genvor undertakes no obligation to update forward-looking statements except as required by applicable law.

For more information contact:

Copyright 2026 ACCESS Newswire. All Rights Reserved.